Table 1. Log2 (posttherapy serum marker... | American Society of Hematology

Table 1.

Log2 (posttherapy serum marker level) and survival by univariate Cox regression

Biomarker	Landmark PFS*		Landmark OS†
Biomarker	P	HR (95% CI)	P	HR (95% CI)
CD163	.3004	0.8 (0.47-1.27)	.5835	0.7 (0.26- 2.13)
IL-10	.0015	1.4 (1.15-1.81)	<.0001	2.0 (1.42-2.77)
MDC	.0430	2.0 (1.01-4.03)	.0198	3.5 (1.22-9.93)
TARC	<.0001	1.9 (1.44-2.49)	.0018	2.2 (1.35-3.69)

Biomarker	Landmark PFS*		Landmark OS†
Biomarker	P	HR (95% CI)	P	HR (95% CI)
CD163	.3004	0.8 (0.47-1.27)	.5835	0.7 (0.26- 2.13)
IL-10	.0015	1.4 (1.15-1.81)	<.0001	2.0 (1.42-2.77)
MDC	.0430	2.0 (1.01-4.03)	.0198	3.5 (1.22-9.93)
TARC	<.0001	1.9 (1.44-2.49)	.0018	2.2 (1.35-3.69)

Total samples, 151; number of events, 34.

Total samples, 151; number of events, 8.